UK Partners with Nobel Prize Winner's Biotech to Produce Cancer Therapies from Nuclear Waste
核心洞察
The UK Nuclear Decommissioning Authority (搜索) has signed a landmark agreement with Bicycle Therapeutics to produce tens of thousands of doses of advanced cancer (搜索) therapies annually using reprocessed uranium from historic nuclear fuel processing.
The partnership will extract lead-212, a valuable medical isotope, from up to 400 tonnes of reprocessed uranium over 15 years to create targeted radiopharmaceuticals (搜索) for hard-to-treat cancers including prostate and neuroendocrine tumors.
Bicycle Therapeutics, co-founded by Nobel Prize winner Sir Greg Winter, will use a novel extraction process developed by the UK National Nuclear Laboratory (搜索) to deliver precision cancer (搜索) treatments that destroy tumors while minimizing damage to healthy tissue.
The UK Nuclear Decommissioning Authority (搜索) has announced a groundbreaking partnership with Bicycle Therapeutics, a cutting-edge biotech firm co-founded by Nobel Prize-winning British scientist Sir Greg Winter, to produce tens of thousands of doses of advanced cancer (搜索) therapies each year using hundreds of tonnes of reprocessed uranium from historic nuclear fuel processing.
The landmark agreement marks a major breakthrough in both cancer (搜索) treatment innovation and the UK's ambition to lead a new era of nuclear-powered medical science. Under the 15-year partnership, Bicycle will gain access to up to 400 tonnes of reprocessed uranium to extract lead-212, a highly valuable medical isotope essential for next-generation cancer treatments.
Revolutionary Radiopharmaceutical Production
The partnership will utilize a novel process developed by the UK National Nuclear Laboratory (搜索) to extract lead-212 from reprocessed uranium. This isotope is crucial for creating radiopharmaceuticals (搜索) that deliver targeted radiotherapy directly to cancer (搜索) cells, destroying tumours while minimising damage to healthy tissue.
Because reprocessed uranium continuously regenerates the necessary isotopes through natural radioactive decay, the supply will sustain the production of tens of thousands of doses of precision cancer (搜索) therapy every year. The extraction will be undertaken using a new radioisotope generator developed exclusively for Bicycle by medical isotope specialists Spectron Rx (搜索).
Targeting Hard-to-Treat Cancers
These radiopharmaceuticals (搜索) offer new hope for cancers that traditional treatments often struggle to treat, including prostate cancer (搜索) and neuroendocrine cancers (搜索) affecting organs such as the pancreas and gut. The precision targeting capability of these therapies represents a significant advancement in oncology treatment options.
Sir Greg Winter, who co-founded Bicycle Therapeutics, is celebrated for his pioneering work in antibody engineering, bringing decades of expertise in developing targeted therapeutic approaches to this innovative partnership.
Government Support and Strategic Vision
Dr Zubir Ahmed, Health Innovation Minister, emphasized the transformative potential of the partnership: "Every breakthrough that gives patients and their loved ones new hope matters deeply – and this extraordinary partnership could be truly life-changing for people facing some of the hardest-to-treat cancers."
The minister highlighted how the initiative showcases British innovation's capacity to transform lives by "turning nuclear material into precision cancer (搜索) treatments" and opening "new frontiers in the fight against this deadly disease."
Strengthening UK Healthcare Infrastructure
The partnership strengthens the UK's wider mission to overhaul cancer (搜索) diagnosis and treatment across the NHS. Recent data shows significant progress, with 110,000 more patients diagnosed or having cancer ruled out within 28 days of an urgent GP or screening referral between November 2024 and October 2025, compared with the previous year.
This initiative builds on a £20 million investment announced last month to support research into lead-212 extraction by UKNNL and Medicines Discovery Catapult (搜索). Investments in new diagnostic hubs, digital infrastructure, and precision therapeutics form a central part of the government's strategy to detect cancer (搜索) earlier, treat it more effectively, and save more lives.
Nuclear Innovation Renaissance
The partnership arrives amid renewed national momentum in nuclear science and technology. Recent government support for Sizewell C on the Suffolk coast and small modular reactors in North Wales reflects a growing focus on nuclear innovation for both clean energy and medical science.
The agreement demonstrates how the UK can repurpose existing nuclear materials to drive life-saving healthcare breakthroughs, reinforce national scientific leadership, and unlock entirely new capabilities in precision cancer (搜索) therapy. This approach represents a paradigm shift in utilizing nuclear waste materials for beneficial medical applications, potentially setting a global precedent for similar initiatives.